WHO WE SERVE
Built for Every Stakeholder in the Medical Cannabinoid Ecosystem.
CCDI™ is being designed to serve the full range of participants in the medical cannabinoid ecosystem, from patients navigating state programs to health systems, regulators, and technology partners building the infrastructure of an emerging medical field.
Patients and Consumers
Navigating medical cannabis programs with better information and more coordinated care.
Millions of patients participate in state-authorized medical cannabis programs. Most do so without the clinical coordination, decision support, or care integration that accompanies other therapeutic areas. Patients often navigate program enrollment, product selection, and ongoing use without visibility into clinical evidence, without integration with their broader care team, and without a structured way to report outcomes or receive follow-up guidance.
CCDI™ is being designed to change that. The platform is intended to support patients with evidence-informed context, care coordination pathways, and the ability to connect their cannabinoid therapy with their broader health picture.
Program Navigation Support
Clearer pathways through state medical cannabis program enrollment, eligibility, and ongoing participation requirements.
Evidence-Informed Context
Access to relevant clinical evidence and condition-specific information to support more informed conversations with care providers.
Care Coordination
Tools to connect cannabinoid therapy with the broader care team, reducing the information gaps that currently exist between patients, practitioners, and dispensaries.
Outcome Capture
Structured pathways for patients to report outcomes and experiences, contributing to the real-world evidence base while supporting their own ongoing care.
Healthcare Practitioners
Evidence-informed decision support at the point of care, integrated with existing clinical workflows.
Physicians, nurse practitioners, physician assistants, and other licensed practitioners who certify patients for medical cannabis programs or manage patients who use cannabinoid therapy currently do so with limited decision support. Clinical evidence is scattered, product information is not standardized, and the data systems that support conventional prescribing and therapeutics are largely disconnected from the medical cannabinoid space.
CCDI™ is being designed to bring clinical decision intelligence into the environments practitioners already use, including EHR systems and clinical workflow platforms, without requiring practitioners to navigate separate tools or systems.
Point-of-Care Decision Support
Evidence-informed guidance integrated into existing EHR and clinical workflow systems, available at the moment of clinical decision-making.
Drug Interaction Screening
Support for identifying potential interactions between cannabinoid therapy and conventional medications, drawing on available clinical evidence.
Patient Visibility
Improved visibility into what patients are using, enabling more complete medication histories and more coordinated care.
Continuing Education Pathways
Access to practitioner education resources and clinical evidence summaries to support ongoing competency in medical cannabinoid therapy.
Licensed Dispensaries
Clinical and operational intelligence for regulated retail, connecting dispensary data with healthcare and regulatory systems.
Licensed dispensaries operate at the intersection of regulated retail and healthcare, but most do so without the clinical data infrastructure, interoperability tools, or outcomes-measurement frameworks that would connect their operations to the broader healthcare ecosystem. Dispensary staff often provide guidance to patients without access to clinical evidence, patient health context, or standardized product information frameworks.
CCDI™ is being designed to support dispensaries with the clinical and operational intelligence needed to operate more effectively within a healthcare-adjacent environment, including tools for staff education, product-to-patient context, and regulatory data exchange.
Clinical Context at the Counter
Tools to support dispensary staff with relevant clinical context and evidence-informed product information at the point of patient interaction.
Healthcare System Connectivity
Data exchange pathways to connect dispensary operations with EHR systems, health plans, and state regulatory platforms.
Regulatory Data Exchange
Streamlined integration with state seed-to-sale tracking systems and regulatory reporting requirements.
Outcomes Contribution
Infrastructure to capture and contribute dispensing and patient-reported outcome data to the broader real-world evidence base.
Health Plans and PBMs
Data infrastructure for coverage analysis, outcomes measurement, and benefit program design.
Health plans and pharmacy benefit management organizations face growing questions about medical cannabinoid therapy as state programs expand and federal policy evolves. Evaluating coverage options, assessing clinical evidence, measuring outcomes, and designing benefit programs in this space requires data infrastructure and interoperability capabilities that do not yet exist at scale.
CCDI™ is being designed to provide health plans and PBMs with the data exchange, outcomes measurement, and clinical intelligence infrastructure needed to evaluate and potentially integrate medical cannabinoid therapy into benefit program frameworks.
Coverage Analysis Infrastructure
Data and evidence frameworks to support evaluation of medical cannabinoid therapy coverage options and benefit program design.
Outcomes Measurement
Real-world evidence and outcomes data infrastructure to support clinical and economic evaluation of cannabinoid therapy.
Interoperability Pathways
Data exchange connections between benefit management systems and the clinical, dispensing, and regulatory data environments of the medical cannabinoid ecosystem.
Regulatory Readiness
Infrastructure designed to adapt as federal and state regulatory frameworks evolve, supporting benefit program compliance and reporting.
EHR and Health IT Companies
Interoperability and integration partnerships to bring cannabinoid clinical intelligence into existing health information systems.
Electronic health record vendors and health information technology companies are increasingly asked by health systems, practitioners, and regulators to support medical cannabinoid documentation, decision support, and data exchange. Most current EHR platforms lack the clinical content, interoperability standards, and integration frameworks needed to address these requests effectively.
CCDI™ is being designed as an integration partner for EHR and health IT companies, providing the clinical content, data standards, and interoperability infrastructure needed to extend existing platforms into the medical cannabinoid space without requiring vendors to build this capability independently.
Clinical Content Integration
Evidence-informed clinical decision support content and drug interaction data designed for integration into existing EHR clinical decision support frameworks.
FHIR-Based Data Standards
Standardized data models and HL7 FHIR-based exchange protocols for cannabinoid clinical data, designed for integration with existing health IT infrastructure.
Dispensary and Registry Connectivity
Integration pathways connecting EHR platforms with dispensary systems, state registries, and product databases through standardized APIs.
Technology Partnership
Collaborative development and integration partnerships to extend EHR platform capabilities into the medical cannabinoid space.
State Agencies and Regulators
Compliance, reporting, and program intelligence infrastructure to support state medical cannabis program administration.
State agencies administering medical cannabis programs manage complex regulatory environments with limited data infrastructure for program evaluation, outcomes measurement, and cross-system data exchange. Most state programs operate seed-to-sale tracking systems that capture product movement but lack the clinical data integration needed to evaluate program outcomes, support practitioner oversight, or connect with the broader healthcare regulatory environment.
CCDI™ is being designed to support state agencies with the data exchange, program intelligence, and regulatory infrastructure needed to administer medical cannabis programs more effectively and to connect state program data with clinical and healthcare systems.
Program Intelligence
Aggregated program data, outcomes analytics, and reporting infrastructure to support evidence-based program administration and evaluation.
Seed-to-Sale Integration
Enhanced connectivity between state tracking systems and clinical, dispensing, and patient data environments.
Regulatory Reporting
Streamlined data exchange and reporting tools to support compliance monitoring, program oversight, and regulatory reporting requirements.
Interstate Data Frameworks
Infrastructure designed to support data exchange and program alignment across state programs as federal frameworks evolve.
All Stakeholders
Every Part of the Ecosystem Has a Role.
Find Your Place in the CCDI™ Ecosystem.
We are actively seeking collaborators across every stakeholder group. Whether you are a health system, technology partner, state agency, research institution, or dispensary operator, we want to hear from you.